What is the recommended initial approach to start antihypertensive medication for hypertension?

How to Start Hypertension Medications

For most patients with newly diagnosed hypertension, initiate treatment with two first-line antihypertensive agents from different classes, preferably as a single-pill combination, especially if blood pressure is ≥20/10 mmHg above target or if the patient has stage 2 hypertension (≥140/90 mmHg). 1, 2

Initial Drug Selection Strategy

Stage 2 Hypertension (BP ≥140/90 mmHg or ≥20/10 mmHg above target)

• Start with dual combination therapy immediately using two first-line agents from different classes 2
• Strongly prefer single-pill combinations to improve adherence and achieve rapid blood pressure control 1, 3
• The most effective initial combinations include:
  • ACE inhibitor or ARB + calcium channel blocker (preferred combination with fewer adverse effects and better outcomes) 4
  • ACE inhibitor or ARB + thiazide diuretic 1
  • Calcium channel blocker + thiazide diuretic 1
• Avoid thiazide diuretic + beta-blocker combinations as initial therapy due to higher adverse effect rates 4

Stage 1 Hypertension (BP 130-139/80-89 mmHg)

• Monotherapy is reasonable for stage 1 hypertension with subsequent titration and sequential addition of agents 2
• However, combination therapy may still be preferable even in stage 1 hypertension to achieve faster control and improve persistence 4, 3

Preferred First-Line Drug Classes

The five major antihypertensive drug classes are all acceptable as first-line agents, but thiazide-type diuretics (especially chlorthalidone) or calcium channel blockers should be prioritized for most patients without specific comorbidities 2:

• Thiazide-type diuretics (chlorthalidone preferred over hydrochlorothiazide for better efficacy and cardiovascular outcomes) 2, 4
• Calcium channel blockers (as effective as diuretics for all cardiovascular events except heart failure) 2
• ACE inhibitors or ARBs 1, 2
• Beta-blockers (less effective than other classes, particularly for stroke prevention; reserve for specific indications like heart failure or coronary disease) 2

Race-Specific Considerations

• For Black patients: Initial therapy should include a calcium channel blocker or thiazide diuretic, either alone or combined with a RAS blocker 1
• ACE inhibitors are notably less effective in Black patients for blood pressure lowering and stroke prevention compared to calcium channel blockers and thiazides 2
• ARBs may be better tolerated than ACE inhibitors in Black patients (less cough and angioedema) but offer no proven advantage over thiazides or calcium channel blockers 2

Blood Pressure Targets

• Target BP <130/80 mmHg for most patients based on the most recent guidelines 1, 5
• For patients with chronic kidney disease (eGFR >30 mL/min/1.73 m²): Target systolic BP 120-129 mmHg if tolerated 1
• For patients with history of stroke or TIA: Target systolic BP 120-130 mmHg 1

Monitoring and Titration

• Home blood pressure monitoring (HBPM) using the 722 protocol is superior to office measurements for guiding therapy: duplicate readings twice daily over seven consecutive days 5
• Titrate medications every 2-4 weeks until target blood pressure is achieved
• Add sequential agents from different classes if dual therapy is insufficient 2

Common Pitfalls to Avoid

• Do not use beta-blockers as first-line monotherapy unless specific indications exist (heart failure, coronary disease) 2
• Do not use alpha-blockers as first-line therapy as they are less effective for cardiovascular disease prevention 2
• Do not use hydrochlorothiazide when chlorthalidone is available due to inferior efficacy 2, 4
• Do not delay combination therapy in stage 2 hypertension attempting sequential monotherapy 2, 3
• Do not overlook medication adherence as a primary cause of apparent treatment resistance 6